USAntibiotics Plans Bristol, Tennessee, Research-Manufacturing Campus
09/03/2021
Located at 201 Industrial Drive, the 360,000-square-foot facility was acquired by Jackson Healthcare with plans to re-open the former pharmaceutical manufacturing site.
“USAntibiotics is focused on what it does best, producing life-saving antibiotics and making them accessible to all Americans. We are proud to have our operations in the state of Tennessee and of the role we play in manufacturing high-quality, made in America products that support health and wellness and that reduce our dependence on vital medications produced outside our country” said Rick Jackson, CEO, Jackson Healthcare, parent company of USAntibiotics.
“We are proud to support USAntibiotics in its critical mission to manufacture two of the most commonly prescribed antibiotics in the country. Tennessee offers companies around the globe a business-friendly climate and skilled workforce, and we are pleased to welcome USAntibiotics to the state as it sets up new operations in Sullivan County,” noted TNECD Commissioner Bob Rolfe.
The Department of Homeland Security has identified USAntibiotics as critical infrastructure since it is the only manufacturing facility in the United States that is authorized to produce Amoxicillin and Amoxicillin Clavulanate, commonly known as Amoxil and Augmentin. These are two of the most widely prescribed antibiotics in the U.S. and this investment will greatly bolster the U.S.’ capabilities to produce its own essential antibiotics.
“We are known for being a leader in a lot of things here, the Birthplace of Country Music, the first public utility to win a Malcolm Baldrige Award with BTES, the World’s Fastest Half Mile at Bristol Motor Speedway, so why not Bristol, Tennessee as the reshoring center of our nation’s antibiotic production. It’s this culture, particularly in our workforce, that was the real difference maker in attracting US Antibiotics. This is a great fit of a company and a community and I’m excited to see all of the great things the future has in store for US Antibiotics, Bristol and Northeast Tennessee,” said David Wagner, Bristol Industrial Development Board chairman, vice-chairman of NETWORKS Sullivan County Partnership.
Project Announcements
Kimberly-Clark Expands Aiken County, South Carolina, Distribution Operations
05/04/2025
Aerowerks Plans Gaffney, South Carolina, Manufacturing Operations
05/04/2025
Sweden-Based Troax Group Plans Portland, Tennessee, Manufacturing Operations
05/04/2025
Kimberly-Clark Corporation Plans Warren, Ohio, Manufacturing Operations
05/04/2025
Denmark-Based Novonesis Expands Salem, Virginia, Production Operations
05/04/2025
Polyvlies USA Expands Winston-Salem, North Carolina, Manufacturing Operations
05/04/2025
Most Read
-
Run a Job Task Analysis
Q4 2024
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
The Location Economics of Advanced Nuclear
Q1 2025
-
Why Workforce Readiness Can’t Wait
Q1 2025
-
Power, Policy, and Site Selection in 2025
Q1 2025
-
Is It Time to Start Planning for Quantum Data Centers?
Q1 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024